Home » Topics » BioWorld Science

BioWorld Science
RSS

E-7011, a neutralizing antibody targeting Notch4 to inhibit tumor growth

April 12, 2022

New small molecules synergize with ciprofloxacin against S. tiphy biofilms in the gallbladder

April 12, 2022

TLR9 inhibitor-loaded nanoparticles protect against radiation-induced BBB disruption

April 12, 2022

Targeting 5-HT1AR as novel therapeutic strategy for Fragile X syndrome

April 12, 2022

IMP-2 validated as cancer target, small-molecule inhibitors identified

April 12, 2022

Inhibition of kininase I prevents angiotensin II-induced hypertension

April 12, 2022

BCAT deletion from T cells may offer advantage to lymphoma immunotherapy

April 12, 2022

Phytos identifies new PD-L1 inhibitors

April 12, 2022

Zhejiang Hisun Pharmaceutical, Hisun Accuray Therapeutics patent anticoagulants

April 12, 2022

New N-myristoyltransferase inhibitors presented by MyricX Pharma, Imperial Innovations Group

April 12, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...